C07D 223/02
Not condensed with other rings
Official title: not condensed with other rings
C07D223/02 (Not condensed with other rings) appears on 880 US grants and 759 published applications in this corpus.
Search patents in C07D- Granted patents
- 880
- Published applications
- 759
- Assignees
- 441
- Inventors
- 2,440
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 13 | 0 |
| 1978 | 13 | 0 |
| 1979 | 15 | 0 |
| 1980 | 13 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 11 | 0 |
| 1984 | 4 | 0 |
| 1985 | 13 | 0 |
| 1986 | 16 | 0 |
| 1987 | 9 | 0 |
| 1988 | 11 | 0 |
| 1989 | 20 | 0 |
| 1990 | 6 | 0 |
| 1991 | 10 | 0 |
| 1992 | 13 | 0 |
| 1993 | 13 | 0 |
| 1994 | 9 | 0 |
| 1995 | 11 | 0 |
| 1996 | 15 | 0 |
| 1997 | 25 | 0 |
| 1998 | 14 | 0 |
| 1999 | 25 | 0 |
| 2000 | 18 | 0 |
| 2001 | 18 | 1 |
| 2002 | 21 | 32 |
| 2003 | 26 | 29 |
| 2004 | 20 | 37 |
| 2005 | 18 | 33 |
| 2006 | 28 | 32 |
| 2007 | 17 | 29 |
| 2008 | 22 | 22 |
| 2009 | 21 | 32 |
| 2010 | 16 | 33 |
| 2011 | 15 | 29 |
| 2012 | 10 | 23 |
| 2013 | 25 | 43 |
| 2014 | 27 | 29 |
| 2015 | 28 | 47 |
| 2016 | 34 | 34 |
| 2017 | 42 | 36 |
| 2018 | 23 | 28 |
| 2019 | 26 | 29 |
| 2020 | 22 | 28 |
| 2021 | 17 | 29 |
| 2022 | 25 | 32 |
| 2023 | 19 | 23 |
| 2024 | 10 | 21 |
| 2025 | 16 | 33 |
| 2026 | 7 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for producing epsilon-caprolactam by depolymerization of polycaprolactam (PA6)18 Aug 2026US 12,709,599 B2Aquafil S.P.A.
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Inorganic solid silicon-based sulfonic acid and/or phosphoric acid catalyst, preparation method therefor, and application thereof24 Mar 2026US 12,582,970 B2Xiangtan University
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Method for purifying a crystalline substance1 Oct 2026US 2026/0297051 A1China Petroleum & Chemical Corporation
- Dpp1 inhibitors with polycyclic linkers and uses thereof10 Sep 2026US 2026/0265207 A1Insmed Incorporated
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Gba1 and gcs dual modulator20 Aug 2026US 2026/0242368 A1Ono Pharmaceutical Co., Ltd.
- Method for manufacturing cyclic lactam and device for manufacturing cyclic lactam13 Aug 2026US 2026/0234105 A1Mitsubishi Gas Chemical Company, Inc.
Most cited
By later US patents
- Apparatus for manufacturing profile pipes used in well construction123US 5,119,661 A1992
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996